Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Immuneering Corporation (IMRX) had Normalized Income after Taxes of $-11.58M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-11.58M |
|
-- |
|
-- |
|
$13.75M |
|
$-13.75M |
|
$2.17M |
|
$-11.58M |
|
$-11.58M |
|
$-11.58M |
|
$-11.58M |
|
$-11.58M |
|
|
Normalized Income after Taxes |
$-11.58M |
$-13.75M |
|
$-13.74M |
|
44.01M |
|
44.01M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$176.25M |
|
$0.94M |
|
$55.74M |
|
$231.99M |
|
$10.07M |
|
-- |
|
$3.43M |
|
$13.50M |
|
$218.48M |
|
$211.47M |
|
$218.48M |
|
64.65M |
|
| Cash Flow Statement Financials | |
$-45.34M |
|
$-88.74M |
|
$226.58M |
|
$36.14M |
|
$128.65M |
|
$92.50M |
|
$6.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-45.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.30% |
|
-5.48% |
|
-4.99% |
|
-5.30% |
|
$3.38 |
|
$-1.03 |
|
$-1.03 |
|